The Human HER2 oncogene, also known as neu/c-erbB2, is responsible for encoding a 185-kDa transmembrane receptor tyrosine kinase overexpressed in 20–30% of breast cancers and is associated with increased breast cancer recurrence and a worse prognosis (23). This evidence concerns the gene ERBB2 and breast carcinoma.